Feng Li, Chaoqi Zhang, Luyu Huang, Ziming Wang, Guanchao Ye, Zhuoyu Gu et al. Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-15582-6. – URL: https://doi.org/10.1186/s12885-026-15582-6
Feng Li, Chaoqi Zhang, Luyu Huang, Ziming Wang, Guanchao Ye, Zhuoyu Gu, & Yu Qi (2026). Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study. BMC Cancer. https://doi.org/10.1186/s12885-026-15582-6
Feng Li, et al. “Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study.” BMC Cancer, 2026. doi:10.1186/s12885-026-15582-6.
@article{Li2026,
title = {Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study},
author = {Li, Feng and Zhang, Chaoqi and Huang, Luyu and Wang, Ziming and Ye, Guanchao and Gu, Zhuoyu and Qi, Yu},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-15582-6},
url = {https://doi.org/10.1186/s12885-026-15582-6}
}